Go to The Journal of Clinical Investigation
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Transfers
  • Advertising
  • Job board
  • Contact
  • Physician-Scientist Development
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Immunology
    • Metabolism
    • Nephrology
    • Oncology
    • Pulmonology
    • All ...
  • Videos
  • Collections
    • In-Press Preview
    • Resource and Technical Advances
    • Clinical Research and Public Health
    • Research Letters
    • Editorials
    • Perspectives
    • Physician-Scientist Development
    • Reviews
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • In-Press Preview
  • Resource and Technical Advances
  • Clinical Research and Public Health
  • Research Letters
  • Editorials
  • Perspectives
  • Physician-Scientist Development
  • Reviews
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Transfers
  • Advertising
  • Job board
  • Contact
Alveolar type II epithelial cell FASN maintains lipid homeostasis in experimental COPD
Li-Chao Fan, … , Jin-Fu Xu, Suzanne M. Cloonan
Li-Chao Fan, … , Jin-Fu Xu, Suzanne M. Cloonan
Published August 22, 2023
Citation Information: JCI Insight. 2023;8(16):e163403. https://doi.org/10.1172/jci.insight.163403.
View: Text | PDF
Research Article Metabolism Pulmonology

Alveolar type II epithelial cell FASN maintains lipid homeostasis in experimental COPD

  • Text
  • PDF
Abstract

Alveolar epithelial type II (AEC2) cells strictly regulate lipid metabolism to maintain surfactant synthesis. Loss of AEC2 cell function and surfactant production are implicated in the pathogenesis of the smoking-related lung disease chronic obstructive pulmonary disease (COPD). Whether smoking alters lipid synthesis in AEC2 cells and whether altering lipid metabolism in AEC2 cells contributes to COPD development are unclear. In this study, high-throughput lipidomic analysis revealed increased lipid biosynthesis in AEC2 cells isolated from mice chronically exposed to cigarette smoke (CS). Mice with a targeted deletion of the de novo lipogenesis enzyme, fatty acid synthase (FASN), in AEC2 cells (FasniΔAEC2) exposed to CS exhibited higher bronchoalveolar lavage fluid (BALF) neutrophils, higher BALF protein, and more severe airspace enlargement. FasniΔAEC2 mice exposed to CS had lower levels of key surfactant phospholipids but higher levels of BALF ether phospholipids, sphingomyelins, and polyunsaturated fatty acid–containing phospholipids, as well as increased BALF surface tension. FasniΔAEC2 mice exposed to CS also had higher levels of protective ferroptosis markers in the lung. These data suggest that AEC2 cell FASN modulates the response of the lung to smoke by regulating the composition of the surfactant phospholipidome.

Authors

Li-Chao Fan, Keith McConn, Maria Plataki, Sarah Kenny, Niamh C. Williams, Kihwan Kim, Jennifer A. Quirke, Yan Chen, Maor Sauler, Matthias E. Möbius, Kuei-Pin Chung, Estela Area Gomez, Augustine M.K. Choi, Jin-Fu Xu, Suzanne M. Cloonan

×

Figure 5

Targeted deletion of FASN in AEC2 cells results in increased lung injury, inflammation, and airspace enlargement upon acute or chronic smoke exposure.

Options: View larger image (or click on image) Download as PowerPoint
Targeted deletion of FASN in AEC2 cells results in increased lung injury...
(A) Schematic of timeline of FasniΔAEC2 and control SftpcCreERT2+/– mice exposed to acute (6 weeks) or chronic (8 months) CS exposure. (B) Total BALF leukocyte counts, (C) total macrophage counts, (D) total neutrophil counts (n = 9–10 mice per group), and (E) total protein concentrations in BALF (n = 6–9 mice per group, n = 2 technical replicates) of FasniΔAEC2 and control SftpcCreERT2+/– mice after acute (6 weeks) CS exposure. (F) Schematic of treatment regimen with the FASN inhibitor C75 and smoke. (G) Plasma free fatty acid levels (n = 5 mice per group), (H) total BALF leukocytes, and (I) total BALF macrophages of mice administered C75 (1 mg/kg 1–7 days, 2.5 mg/kg days 7–13, 5 mg/kg days 14–22, then 10 mg/kg days 23–42, DMSO as control) for a total of 42 days of exposure to CS. (n = 4–5 mice per group.) (J) Representative IHC images of modified gills-stained lung sections (top) and MCL scoring (bottom) of mouse lungs for each group (n = 8–15 mice per group) calculated from FasniΔAEC2 and SftpcCreERT2+/– control mice, as well as C57BL/6 controls exposed to 8 months of CS exposure. (K) Representative IHC image of TUNEL stain of lung tissue from FasniΔAEC2 and SftpcCreERT2+/– control mice exposed to 8 months of CS with corresponding quantification norm (right). (L) Densitometric analysis of fold-change in p53 expression by immunoblotting in the whole lung tissue of FasniΔAEC2 and SftpcCreERT2+/– control mice exposed to 6 months of CS (n = 3 mice per group) normalized to β-actin. Scale bars, 50 μm. Data represented as mean ± SEM of 1 independent experiment. *P < 0.05 by 1-way ANOVA followed by Tukey’s correction. #P < 0.05 by Student’s unpaired t test.

Copyright © 2025 American Society for Clinical Investigation
ISSN 2379-3708

Sign up for email alerts